Comparative performance data for multiplex SARS-CoV-2 serological assays from a large panel of dried blood spot specimens.

Covid-19 Dried blood spots Immunoassays SARS-CoV-2 Serology Serosurveys

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 10 06 2022
revised: 06 08 2022
accepted: 09 08 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 6 9 2022
Statut: ppublish

Résumé

The extent of the COVID-19 pandemic will be better understood through serosurveys and SARS-CoV-2 antibody testing. Dried blood spot (DBS) samples will play a central role in large scale serosurveillance by simplifying biological specimen collection and transportation, especially in Canada. Direct comparative performance data on multiplex SARS-CoV-2 assays resulting from identical DBS samples are currently lacking. In our study, we aimed to provide performance data for the BioPlex 2200 SARS-CoV-2 IgG (Bio-Rad), V-PLEX SARS-CoV-2 Panel 2 IgG (MSD), and Elecsys Anti-SARS-CoV-2 (Roche) commercial assays, as well as for two highly scalable in-house assays (University of Ottawa and Mount Sinai Hospital protocols) to assess their suitability for DBS-based SARS-CoV-2 DBS serosurveillance. These assays were evaluated against identical panels of DBS samples collected from convalescent COVID-19 patients (

Identifiants

pubmed: 36060461
doi: 10.1016/j.heliyon.2022.e10270
pii: S2405-8440(22)01558-4
pmc: PMC9420314
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e10270

Informations de copyright

Crown Copyright © 2022 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Infect Control Hosp Epidemiol. 2021 Jun 24;:1-4
pubmed: 34167599
Sci Rep. 2021 Apr 8;11(1):7754
pubmed: 33833246
PLoS One. 2021 Mar 15;16(3):e0248218
pubmed: 33720928
Clin Infect Dis. 2021 Aug 2;73(3):e699-e709
pubmed: 33400782
Open Forum Infect Dis. 2021 Dec 23;9(2):ofab632
pubmed: 35103246
Arch Pathol Lab Med. 2021 Apr 1;145(4):415-418
pubmed: 33264390
PLoS One. 2020 Dec 31;15(12):e0244126
pubmed: 33382764
Clin Biochem. 2021 Nov;97:54-61
pubmed: 34453893
J Clin Virol Plus. 2021 Jun;1(1):100014
pubmed: 35262002
Clin Infect Dis. 2021 Dec 16;73(12):2366-2368
pubmed: 33693643
N Engl J Med. 2022 Mar 24;386(12):1176-1179
pubmed: 35196425
Clin Chim Acta. 2020 Oct;509:18-21
pubmed: 32485155
Front Med (Lausanne). 2021 May 07;8:615099
pubmed: 34026773
Emerg Infect Dis. 2020 Dec;26(12):2970-2973
pubmed: 32969788
Clin Transl Immunology. 2022 Mar 23;11(3):e1380
pubmed: 35356067
PLoS One. 2021 Dec 7;16(12):e0261003
pubmed: 34874948
Microbiol Spectr. 2021 Oct 31;9(2):e0129821
pubmed: 34668728
Diagn Microbiol Infect Dis. 2021 Sep;101(1):115425
pubmed: 34116343
J Virol Methods. 2021 Mar;289:114060
pubmed: 33359614
EBioMedicine. 2021 Aug;70:103502
pubmed: 34333234
Microorganisms. 2021 Jan 25;9(2):
pubmed: 33504067
Clin Chem Lab Med. 2020 Nov 19;59(2):411-419
pubmed: 33554506
Nat Rev Microbiol. 2021 Mar;19(3):171-183
pubmed: 33057203
Sci Rep. 2020 Nov 19;10(1):20188
pubmed: 33214612
J Infect. 2020 Aug;81(2):e39-e45
pubmed: 32504735
Viruses. 2021 May 22;13(6):
pubmed: 34067361
BMC Cancer. 2015 Apr 11;15:265
pubmed: 25886002
J Clin Med. 2020 Nov 21;9(11):
pubmed: 33233405
Microbiol Spectr. 2022 Apr 27;10(2):e0140521
pubmed: 35266818
Can Commun Dis Rep. 2020 Nov 05;46(11-12):422-426
pubmed: 33776588
GMS Infect Dis. 2020 Sep 16;8:Doc22
pubmed: 32983837
Front Public Health. 2017 Nov 20;5:307
pubmed: 29209603
Pract Lab Med. 2021 May;25:e00234
pubmed: 33942023
Sci Rep. 2021 Mar 23;11(1):6614
pubmed: 33758278
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
Clin Chem Lab Med. 2021 Jan 08;59(5):979-985
pubmed: 33554537
J Clin Microbiol. 2021 May 19;59(6):
pubmed: 33795412
Mol Cell Proteomics. 2017 Jul;16(7):1286-1296
pubmed: 28501802
Front Microbiol. 2020 Mar 09;11:373
pubmed: 32210946
J Clin Virol. 2021 Mar;136:104739
pubmed: 33588354
EJIFCC. 2009 Jan 20;19(4):203-11
pubmed: 27683318
Front Cell Infect Microbiol. 2022 Jan 18;11:781429
pubmed: 35118007
Ann Clin Biochem. 2021 Mar;58(2):123-131
pubmed: 33269949
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
Drug Test Anal. 2021 Jan;13(1):223-226
pubmed: 33119946
Nature. 2021 Feb;590(7846):382-384
pubmed: 33594289
Clin Chem Lab Med. 2020 Jul 28;58(8):1357-1364
pubmed: 32447328
PLoS One. 2021 Jun 23;16(6):e0252617
pubmed: 34161316
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
PLoS One. 2020 Apr 14;15(4):e0231385
pubmed: 32287293
PLoS Pathog. 2022 Feb 8;18(2):e1010248
pubmed: 35134084

Auteurs

François Cholette (F)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Canada.

Rissa Fabia (R)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Angela Harris (A)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Hannah Ellis (H)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Karla Cachero (K)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Lukas Schroeder (L)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Christine Mesa (C)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Philip Lacap (P)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Corey Arnold (C)

Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.

Yannick Galipeau (Y)

Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.

Marc-André Langlois (MA)

Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Canada.
The Centre for Infection, Immunity, and Inflammation (CI3), University of Ottawa, Ottawa, Canada.

Karen Colwill (K)

Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, Canada.

Anne-Claude Gingras (AC)

Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Canada.

Allison McGeer (A)

Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health, Toronto, Canada.
Department of Microbiology at Mount Sinai Hospital, Sinai Health, Toronto, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Canada.

Elizabeth Giles (E)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Jacqueline Day (J)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Carla Osiowy (C)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Yves Durocher (Y)

Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, Canada.

Catherine Hankins (C)

Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Canada.

Bruce Mazer (B)

Department of Pediatrics, McGill University, Montréal, Canada.

Michael Drebot (M)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

John Kim (J)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.

Classifications MeSH